Lazarus AH - Search Results

1

Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia.

Vollenberg R, Jouni R, Norris PAA, Burg-Roderfeld M, Cooper N, Rummel MJ, Bein G, Marini I, Bayat B, Burack R, Lazarus AH, Bakchoul T, Sachs UJ. Vollenberg R, et al. Among authors: lazarus ah. Haematologica. 2019 Jun;104(6):1237-1243. doi: 10.3324/haematol.2018.211086. Epub 2019 Mar 28. Haematologica. 2019. PMID: 30923095 Free PMC article.

2

Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.

Song S, Crow AR, Freedman J, Lazarus AH. Song S, et al. Among authors: lazarus ah. Blood. 2003 May 1;101(9):3708-13. doi: 10.1182/blood-2002-10-3078. Epub 2002 Dec 27. Blood. 2003. PMID: 12506021 Free article.

3

Intravenous immunoglobulin inhibits anti-glycoprotein IIb-induced platelet apoptosis in a murine model of immune thrombocytopenia.

Leytin V, Mykhaylov S, Starkey AF, Allen DJ, Lau H, Ni H, Semple JW, Lazarus AH, Freedman J. Leytin V, et al. Among authors: lazarus ah. Br J Haematol. 2006 Apr;133(1):78-82. doi: 10.1111/j.1365-2141.2006.05981.x. Br J Haematol. 2006. PMID: 16512832 Free article.

4

Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia.

Crow AR, Song S, Siragam V, Lazarus AH. Crow AR, et al. Among authors: lazarus ah. Pediatr Blood Cancer. 2006 Oct 15;47(5 Suppl):710-3. doi: 10.1002/pbc.20980. Pediatr Blood Cancer. 2006. PMID: 16933274 Review.

5

The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?

Crow AR, Lazarus AH. Crow AR, et al. Among authors: lazarus ah. Transfus Med Rev. 2008 Apr;22(2):103-16. doi: 10.1016/j.tmrv.2007.12.001. Transfus Med Rev. 2008. PMID: 18353251 Review.

6

A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy.

Chow L, Aslam R, Speck ER, Kim M, Cridland N, Webster ML, Chen P, Sahib K, Ni H, Lazarus AH, Garvey MB, Freedman J, Semple JW. Chow L, et al. Among authors: lazarus ah. Blood. 2010 Feb 11;115(6):1247-53. doi: 10.1182/blood-2009-09-244772. Epub 2009 Dec 10. Blood. 2010. PMID: 20007808 Free article.

7

The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia.

Crow AR, Suppa SJ, Chen X, Mott PJ, Lazarus AH. Crow AR, et al. Among authors: lazarus ah. Blood. 2011 Dec 8;118(24):6403-6. doi: 10.1182/blood-2011-08-374223. Epub 2011 Oct 14. Blood. 2011. PMID: 22001393 Free article.

8

CD44 antibodies and immune thrombocytopenia in the amelioration of murine inflammatory arthritis.

Mott PJ, Lazarus AH. Mott PJ, et al. Among authors: lazarus ah. PLoS One. 2013 Jun 13;8(6):e65805. doi: 10.1371/journal.pone.0065805. Print 2013. PLoS One. 2013. PMID: 23785450 Free PMC article.

9

CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption.

Crow AR, Amash A, Lazarus AH. Crow AR, et al. Among authors: lazarus ah. Transfusion. 2015 Jun;55(6 Pt 2):1492-500. doi: 10.1111/trf.12957. Epub 2014 Dec 15. Transfusion. 2015. PMID: 25496771

10

A monoclonal antibody with anti-D-like activity in murine immune thrombocytopenia requires Fc domain function for immune thrombocytopenia ameliorative effects.

Yu X, Menard M, Seabright G, Crispin M, Lazarus AH. Yu X, et al. Among authors: lazarus ah. Transfusion. 2015 Jun;55(6 Pt 2):1501-11. doi: 10.1111/trf.13032. Epub 2015 Mar 6. Transfusion. 2015. PMID: 25752470

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters